Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
publishDate:"[2020 TO 2020]"
journalStr:"WHO International Clinical Trials Registry Platform"
format_facet:"Elektronische Ressource"
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=publishDate%3A%22%5B2020+TO+2020%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (856)
1
A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults : A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
2
A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for Eurpean Union/United Kingdom SitesAdaptive COVID-19 Treatment Trial in the EU & UK (ACTT/EU/UK : A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Union/United Kingdom Sites - Adaptive COVID-19 Treatment Trial in the EU & UK (ACTT-EU/UK)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
3
A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults : A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
4
A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for Eurpean Union/United Kingdom SitesAdaptive COVID-19 Treatment Trial in the EU & UK (ACTT/EU/UK : A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Union/United Kingdom Sites - Adaptive COVID-19 Treatment Trial in the EU & UK (ACTT-EU/UK)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
5
A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 : A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 - CALAVI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
6
A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 : A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19 - CALAVI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
7
Investigating the safety, satisfaction and efficacy of pulmonary tele rehabilitation for people with respiratory conditions, including patients recovering from COVID-19. : Impact of pulmonary tele rehabilitation on exercise capacity and health-related quality of life in people with respiratory conditions, including patients recovering from COVID-19.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS) : Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS) - BCG-PLUS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
9
The Loddon Mallee Healthcare Worker COVID-19 Study : The Loddon Mallee Healthcare Worker COVID-19 Study: A longitudinal cohort study exploring the impacts of COVID-19 on the health and wellbeing of the rural and regional health care workforce.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
10
This study will test a drug named remdesivir (GS-5734™) to evaluate the safety and effectiveness of the drug in treating patients with severe coronavirus disease 2019 (COVID-19). : A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 - .
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[86]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Erscheinungsjahr: 2020-2020
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
856
Aufsätze
856
E-Artikel
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
856
610
Recruitment Status: Not yet recruiting
490
Study Type: Interventional
430
Medical Condition: Novel Coronavirus Pneumonia ...
274
Study Type: Observational
112
Phase: Retrospective study
62
Medical Condition: novel coronavirus pneumonia ...
60
Phase: Phase 3
46
Study Type: Diagnostic test
44
Phase: Phase 2
16
Medical Condition: Coronavirus disease 2019 (CO...
14
Medical Condition: COVID-19
12
Study Type: Basic Science
10
Medical Condition: Coronavirus disease 2019 (CO...
10
Medical Condition: Novel coronavirus pneumonia ...
10
Study Type: Prevention
8
Medical Condition: COVID-19;Cancer; COVID-19 Ca...
8
Medical Condition: Severe COVID-19 pneumonia Me...
8
Phase: Phase 1/Phase 2
8
Study Type: Epidemilogical research
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
844
Englisch
10
Unbestimmt
2
Französisch
Haven't found what you're looking for?
Wird geladen...